
Christian C. Boesen
Examiner (ID: 19338, Phone: (571)270-1321 , Office: P/1639 )
| Most Active Art Unit | 1639 |
| Art Unit(s) | 4131, 1684, 1636, 1675, 1639 |
| Total Applications | 1001 |
| Issued Applications | 687 |
| Pending Applications | 83 |
| Abandoned Applications | 262 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18887723
[patent_doc_number] => 11866484
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-01-09
[patent_title] => Synthetic single domain antibody
[patent_app_type] => utility
[patent_app_number] => 17/190626
[patent_app_country] => US
[patent_app_date] => 2021-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 14
[patent_no_of_words] => 14293
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 179
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17190626
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/190626 | Synthetic single domain antibody | Mar 2, 2021 | Issued |
Array
(
[id] => 18485224
[patent_doc_number] => 20230212555
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-06
[patent_title] => METHODS AND COMPOSITIONS FOR IDENTIFYING TRAITS USING A CELL-FREE SYSTEM
[patent_app_type] => utility
[patent_app_number] => 17/802377
[patent_app_country] => US
[patent_app_date] => 2021-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9374
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17802377
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/802377 | METHODS AND COMPOSITIONS FOR IDENTIFYING TRAITS USING A CELL-FREE SYSTEM | Feb 28, 2021 | Pending |
Array
(
[id] => 18286629
[patent_doc_number] => 20230102101
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-30
[patent_title] => HUMAN-LIKE HEAVY CHAIN ANTIBODY VARIABLE DOMAIN (VHH) DISPLAY LIBRARIES
[patent_app_type] => utility
[patent_app_number] => 17/801471
[patent_app_country] => US
[patent_app_date] => 2021-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26348
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17801471
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/801471 | HUMAN-LIKE HEAVY CHAIN ANTIBODY VARIABLE DOMAIN (VHH) DISPLAY LIBRARIES | Feb 28, 2021 | Pending |
Array
(
[id] => 18996157
[patent_doc_number] => 11912989
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-02-27
[patent_title] => Antigen-binding molecules, the antigen-binding activity of which varies according to the concentration of compounds, and libraries of said molecules
[patent_app_type] => utility
[patent_app_number] => 17/182331
[patent_app_country] => US
[patent_app_date] => 2021-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 49
[patent_figures_cnt] => 49
[patent_no_of_words] => 117015
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 139
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17182331
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/182331 | Antigen-binding molecules, the antigen-binding activity of which varies according to the concentration of compounds, and libraries of said molecules | Feb 22, 2021 | Issued |
Array
(
[id] => 18278831
[patent_doc_number] => 20230094303
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-30
[patent_title] => Methods and Systems Involving Digestible Primers for Improving Single Cell Multi-Omic Analysis
[patent_app_type] => utility
[patent_app_number] => 17/799495
[patent_app_country] => US
[patent_app_date] => 2021-02-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27407
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -72
[patent_words_short_claim] => 80
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17799495
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/799495 | Methods and Systems Involving Digestible Primers for Improving Single Cell Multi-Omic Analysis | Feb 11, 2021 | Abandoned |
Array
(
[id] => 17113215
[patent_doc_number] => 20210293812
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-23
[patent_title] => HIGH THROUGHPUT PROCESS FOR T CELL RECEPTOR TARGET IDENTIFICATION OF NATIVELY-PAIRED T CELL RECEPTOR SEQUENCES
[patent_app_type] => utility
[patent_app_number] => 17/170379
[patent_app_country] => US
[patent_app_date] => 2021-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 53386
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17170379
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/170379 | HIGH THROUGHPUT PROCESS FOR T CELL RECEPTOR TARGET IDENTIFICATION OF NATIVELY-PAIRED T CELL RECEPTOR SEQUENCES | Feb 7, 2021 | Abandoned |
Array
(
[id] => 20849925
[patent_doc_number] => 12686950
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-07-21
[patent_title] => Microarrays
[patent_app_type] => utility
[patent_app_number] => 17/800459
[patent_app_country] => US
[patent_app_date] => 2021-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 37
[patent_no_of_words] => 30734
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 144
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17800459
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/800459 | MICROARRAYS | Feb 7, 2021 | Issued |
Array
(
[id] => 16870580
[patent_doc_number] => 20210164047
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-03
[patent_title] => COMPOSITIONS AND METHODS FOR IMMUNE REPERTOIRE SEQUENCING
[patent_app_type] => utility
[patent_app_number] => 17/248722
[patent_app_country] => US
[patent_app_date] => 2021-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 69479
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 206
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17248722
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/248722 | Compositions and methods for immune repertoire sequencing | Feb 3, 2021 | Issued |
Array
(
[id] => 18294631
[patent_doc_number] => 20230104317
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-06
[patent_title] => Systems and Methods to Identify Genetic Silencers and Applications Thereof
[patent_app_type] => utility
[patent_app_number] => 17/759917
[patent_app_country] => US
[patent_app_date] => 2021-02-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10722
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17759917
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/759917 | Systems and Methods to Identify Genetic Silencers and Applications Thereof | Jan 31, 2021 | Pending |
Array
(
[id] => 19013340
[patent_doc_number] => 11920258
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-03-05
[patent_title] => Antibody libraries with maximized antibody developability characteristics
[patent_app_type] => utility
[patent_app_number] => 17/163170
[patent_app_country] => US
[patent_app_date] => 2021-01-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 58
[patent_figures_cnt] => 58
[patent_no_of_words] => 21353
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 260
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17163170
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/163170 | Antibody libraries with maximized antibody developability characteristics | Jan 28, 2021 | Issued |
Array
(
[id] => 18226230
[patent_doc_number] => 20230065224
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-02
[patent_title] => OLIGONUCLEOTIDE ENCODED CHEMICAL LIBRARIES, RELATED SYSTEMS, DEVICES, AND METHODS FOR DETECTING, ANALYZING, QUANTIFYING, AND TESTING BIOLOGICS/GENETICS
[patent_app_type] => utility
[patent_app_number] => 17/795853
[patent_app_country] => US
[patent_app_date] => 2021-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 76903
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 177
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17795853
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/795853 | Oligonucleotide encoded chemical libraries, related systems, devices, and methods for detecting, analyzing, quantifying, and testing biologics/genetics | Jan 27, 2021 | Issued |
Array
(
[id] => 16948438
[patent_doc_number] => 20210207129
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-08
[patent_title] => SIMULTANEOUS, INTEGRATED SELECTION AND EVOLUTION OF ANTIBODY/PROTEIN PERFORMANCE AND EXPRESSION IN PRODUCTION HOSTS
[patent_app_type] => utility
[patent_app_number] => 17/159936
[patent_app_country] => US
[patent_app_date] => 2021-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 40983
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17159936
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/159936 | Simultaneous, integrated selection and evolution of antibody/protein performance and expression in production hosts | Jan 26, 2021 | Issued |
Array
(
[id] => 18227158
[patent_doc_number] => 20230066152
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-02
[patent_title] => METHODS TO CHARACTERIZE ENZYMES FOR GENOME ENGINEERING
[patent_app_type] => utility
[patent_app_number] => 17/794520
[patent_app_country] => US
[patent_app_date] => 2021-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24525
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 164
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17794520
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/794520 | METHODS TO CHARACTERIZE ENZYMES FOR GENOME ENGINEERING | Jan 24, 2021 | Pending |
Array
(
[id] => 18222823
[patent_doc_number] => 20230061817
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-02
[patent_title] => HBV SPECIFIC TCR LIBRARY AND ITS USE AS PERSONALISED MEDICINE
[patent_app_type] => utility
[patent_app_number] => 17/794379
[patent_app_country] => US
[patent_app_date] => 2021-01-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16760
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -46
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17794379
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/794379 | HBV SPECIFIC TCR LIBRARY AND ITS USE AS PERSONALISED MEDICINE | Jan 20, 2021 | Pending |
Array
(
[id] => 18437451
[patent_doc_number] => 20230184746
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-15
[patent_title] => HIGH-SENSITIVITY DETECTION OF GPCR ACTIVITY AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/793615
[patent_app_country] => US
[patent_app_date] => 2021-01-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22064
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -55
[patent_words_short_claim] => 130
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17793615
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/793615 | HIGH-SENSITIVITY DETECTION OF GPCR ACTIVITY AND USES THEREOF | Jan 20, 2021 | Pending |
Array
(
[id] => 17399992
[patent_doc_number] => 20220042082
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-10
[patent_title] => AMPLIFICATION AND ANALYSIS OF SELECTED TARGETS ON SOLID SUPPORTS
[patent_app_type] => utility
[patent_app_number] => 17/151766
[patent_app_country] => US
[patent_app_date] => 2021-01-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26269
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17151766
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/151766 | AMPLIFICATION AND ANALYSIS OF SELECTED TARGETS ON SOLID SUPPORTS | Jan 18, 2021 | Abandoned |
Array
(
[id] => 18209259
[patent_doc_number] => 20230055519
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-23
[patent_title] => METHODS OF IDENTIFYING SYNTHETIC MOLECULAR BINDING AGENTS
[patent_app_type] => utility
[patent_app_number] => 17/793383
[patent_app_country] => US
[patent_app_date] => 2021-01-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25235
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17793383
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/793383 | METHODS OF IDENTIFYING SYNTHETIC MOLECULAR BINDING AGENTS | Jan 15, 2021 | Pending |
Array
(
[id] => 18212406
[patent_doc_number] => 20230058670
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-23
[patent_title] => NOVEL CELLULAR PHENOTYPE SCREENING METHOD
[patent_app_type] => utility
[patent_app_number] => 17/770569
[patent_app_country] => US
[patent_app_date] => 2021-01-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18952
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17770569
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/770569 | Cellular phenotype screening method | Jan 11, 2021 | Issued |
Array
(
[id] => 18213284
[patent_doc_number] => 20230059548
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-23
[patent_title] => SYSTEMS AND METHODS FOR IDENTIFICATION OF MHC-I PEPTIDE EPITOPES
[patent_app_type] => utility
[patent_app_number] => 17/790711
[patent_app_country] => US
[patent_app_date] => 2021-01-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9592
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -94
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17790711
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/790711 | SYSTEMS AND METHODS FOR IDENTIFICATION OF MHC-I PEPTIDE EPITOPES | Jan 3, 2021 | Pending |
Array
(
[id] => 18319792
[patent_doc_number] => 20230117920
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-20
[patent_title] => Library Construction Method, Cyclic Peptide, FXIIa Binder and IFNGR1 Binder
[patent_app_type] => utility
[patent_app_number] => 17/788990
[patent_app_country] => US
[patent_app_date] => 2020-12-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19541
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17788990
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/788990 | Library Construction Method, Cyclic Peptide, FXIIa Binder and IFNGR1 Binder | Dec 24, 2020 | Pending |